---
layout: default
title: EXAONE Path 2.5: Pathology Foundation Model with Multi-Omics Alignment
---

# EXAONE Path 2.5: Pathology Foundation Model with Multi-Omics Alignment

<div class="paper-toolbar">
  <a href="https://arxiv.org/abs/2512.14019" class="toolbar-btn" target="_blank">üìÑ arXiv: 2512.14019v1</a>
  <a href="https://arxiv.org/pdf/2512.14019.pdf" class="toolbar-btn" target="_blank">üì• PDF</a>
  <button class="toolbar-btn favorite-btn" data-arxiv-id="2512.14019v1" onclick="toggleFavorite(this, '2512.14019v1', 'EXAONE Path 2.5: Pathology Foundation Model with Multi-Omics Alignment')" title="Ê∑ªÂä†Âà∞Êî∂ËóèÂ§π">‚òÜ Êî∂Ëóè</button>
  <button class="toolbar-btn" onclick="copyLinkToClipboard(this)">üîó ÂàÜ‰∫´</button>
</div>


**‰ΩúËÄÖ**: Juseung Yun, Sunwoo Yu, Sumin Ha, Jonghyun Kim, Janghyeon Lee, Jongseong Jang, Soonyoung Lee

**ÂàÜÁ±ª**: cs.LG, q-bio.QM

**ÂèëÂ∏ÉÊó•Êúü**: 2025-12-16

---

## üí° ‰∏ÄÂè•ËØùË¶ÅÁÇπ

**ÊèêÂá∫EXAONE Path 2.5‰ª•Ëß£ÂÜ≥Â§öÂ±ÇÊ¨°ËÇøÁò§ÁîüÁâ©Â≠¶Âª∫Ê®°ÈóÆÈ¢ò**

üéØ **ÂåπÈÖçÈ¢ÜÂüü**: **ÊîØÊü±‰∫åÔºöRLÁÆóÊ≥ï‰∏éÊû∂ÊûÑ (RL & Architecture)** **ÊîØÊü±‰πùÔºöÂÖ∑Ë∫´Â§ßÊ®°Âûã (Embodied Foundation Models)**

**ÂÖ≥ÈîÆËØç**: `ÁóÖÁêÜÊ®°Âûã` `Â§öÊ®°ÊÄÅÂ≠¶‰π†` `Á≤æÂáÜËÇøÁò§Â≠¶` `ÁîüÁâ©‰ø°ÊÅØÊï¥Âêà` `ÂØπÊØîÂ≠¶‰π†` `Á©∫Èó¥ÁªìÊûÑ‰øùÁïô` `Âü∫Âõ†ÁªÑÂ≠¶` `ËΩ¨ÂΩïÁªÑÂ≠¶`

## üìã Ê†∏ÂøÉË¶ÅÁÇπ

1. Áé∞ÊúâÊñπÊ≥ï‰∏ªË¶ÅÈõÜ‰∏≠‰∫éÂçï‰∏ÄÊ®°ÊÄÅÔºåÊó†Ê≥ïÂÖ®Èù¢ÂèçÊò†ËÇøÁò§ÁîüÁâ©Â≠¶ÁöÑÂ§çÊùÇÊÄßÔºåÂØºËá¥‰ø°ÊÅØÁöÑ‰∏¢Â§±ÂíåÊ®°ÂûãÁöÑÂ±ÄÈôêÊÄß„ÄÇ
2. ÊèêÂá∫EXAONE Path 2.5ÔºåÈÄöËøáËÅîÂêàÂª∫Ê®°Â§öÁßçÁîüÁâ©Ê®°ÊÄÅÔºåÂà©Áî®Â§öÊ®°ÊÄÅSigLIPÊçüÂ§±ÂíåF-RoPEÊ®°ÂùóÔºåÂ¢ûÂº∫Ê®°ÂûãÂØπËÇøÁò§ÁîüÁâ©Â≠¶ÁöÑÁêÜËß£„ÄÇ
3. Âú®Patho-BenchÂü∫ÂáÜÊµãËØï‰∏≠ÔºåEXAONE Path 2.5‰∏éÂÖ≠‰∏™È¢ÜÂÖàÊ®°ÂûãÁõ∏ÊØîÔºåË°®Áé∞Âá∫Áõ∏ÂΩìÁöÑÊÄßËÉΩÔºåÂêåÊó∂Âú®ÂÜÖÈÉ®‰∏¥Â∫äÊï∞ÊçÆÈõÜ‰∏äÂ±ïÁé∞Âá∫Êõ¥È´òÁöÑÈÄÇÂ∫îÊÄß„ÄÇ

## üìù ÊëòË¶ÅÔºà‰∏≠ÊñáÔºâ

ÁôåÁóáËøõÂ±ïÊ∫ê‰∫éÂ§ö‰∏™ÁîüÁâ©Â±ÇÊ¨°‰πãÈó¥ÁöÑÁõ∏‰∫í‰ΩúÁî®ÔºåÂ∞§ÂÖ∂ÊòØË∂ÖË∂äÂΩ¢ÊÄÅÂ≠¶ÁöÑÂàÜÂ≠êÂ±ÇÈù¢„ÄÇ‰∏∫ÊçïÊçâËøô‰∏ÄÊõ¥ÂπøÊ≥õÁöÑÁîüÁâ©ÊôØËßÇÔºåÊú¨ÊñáÊèêÂá∫EXAONE Path 2.5ÔºåËøôÊòØ‰∏Ä‰∏™ÁóÖÁêÜÂü∫Á°ÄÊ®°ÂûãÔºåËÅîÂêàÂª∫Ê®°ÁªÑÁªáÂ≠¶„ÄÅÂü∫Âõ†ÁªÑ„ÄÅË°®ËßÇÈÅó‰º†Â≠¶ÂíåËΩ¨ÂΩïÁªÑÁ≠âÂ§öÁßçÊ®°ÊÄÅÔºåÁîüÊàêÊõ¥ÂÖ®Èù¢ÁöÑÊÇ£ËÄÖË°®ÂæÅ„ÄÇËØ•ÊñπÊ≥ïÂåÖÂê´‰∏âÂ§ßÊ†∏ÂøÉÁªÑ‰ª∂ÔºöÂ§öÊ®°ÊÄÅSigLIPÊçüÂ§±„ÄÅ‰øùÁïôÁ©∫Èó¥ÁªìÊûÑÁöÑÁâáÊÆµÊÑüÁü•ÊóãËΩ¨‰ΩçÁΩÆÁºñÁ†ÅÊ®°ÂùóÔºàF-RoPEÔºâÔºå‰ª•ÂèäÈíàÂØπWSIÂíåRNA-seqÁöÑÈ¢ÜÂüü‰∏ìÁî®Âü∫Á°ÄÊ®°Âûã„ÄÇÈÄöËøáÂØπÊØîÂÖ≠‰∏™È¢ÜÂÖàÁöÑÁóÖÁêÜÂü∫Á°ÄÊ®°ÂûãÔºåEXAONE Path 2.5Âú®ÂÜÖÈÉ®‰∏¥Â∫äÊï∞ÊçÆÈõÜÂíåPatho-BenchÂü∫ÂáÜ‰∏äÂ±ïÁ§∫‰∫ÜÈ´òÊï∞ÊçÆÂíåÂèÇÊï∞ÊïàÁéáÔºåË°®Áé∞Âá∫‰∏éÊúÄÂÖàËøõÊ®°ÂûãÁõ∏ÂΩìÁöÑÊÄßËÉΩÔºåÂπ∂Âú®ÂÜÖÈÉ®‰∏¥Â∫äÁéØÂ¢É‰∏≠Â±ïÁé∞Âá∫ÊúÄÈ´òÁöÑÈÄÇÂ∫îÊÄß„ÄÇ

## üî¨ ÊñπÊ≥ïËØ¶Ëß£

**ÈóÆÈ¢òÂÆö‰πâ**ÔºöÊú¨ÊñáÊó®Âú®Ëß£ÂÜ≥Áé∞ÊúâÁóÖÁêÜÊ®°ÂûãÂú®Â§öÂ±ÇÊ¨°ÁîüÁâ©‰ø°ÊÅØÊï¥ÂêàÊñπÈù¢ÁöÑ‰∏çË∂≥ÔºåÂ∞§ÂÖ∂ÊòØÊó†Ê≥ïÊúâÊïàÁªìÂêàÂΩ¢ÊÄÅÂ≠¶‰∏éÂàÜÂ≠êÂ±ÇÊ¨°ÁöÑ‰ø°ÊÅØ„ÄÇ

**Ê†∏ÂøÉÊÄùË∑Ø**ÔºöÈÄöËøáËÅîÂêàÂª∫Ê®°ÁªÑÁªáÂ≠¶„ÄÅÂü∫Âõ†ÁªÑ„ÄÅË°®ËßÇÈÅó‰º†Â≠¶ÂíåËΩ¨ÂΩïÁªÑÁ≠âÂ§öÁßçÊ®°ÊÄÅÔºåEXAONE Path 2.5ËÉΩÂ§üÁîüÊàêÊõ¥ÂÖ®Èù¢ÁöÑÊÇ£ËÄÖË°®ÂæÅÔºå‰ªéËÄåÊõ¥Â•ΩÂú∞ÂèçÊò†ËÇøÁò§ÁîüÁâ©Â≠¶„ÄÇ

**ÊäÄÊúØÊ°ÜÊû∂**ÔºöËØ•Ê®°ÂûãÁöÑÊï¥‰ΩìÊû∂ÊûÑÂåÖÊã¨Â§öÊ®°ÊÄÅSigLIPÊçüÂ§±„ÄÅF-RoPEÊ®°ÂùóÂíåÈ¢ÜÂüü‰∏ìÁî®Âü∫Á°ÄÊ®°ÂûãÔºåÁ°Æ‰øù‰∏çÂêåÊ®°ÊÄÅ‰πãÈó¥ÁöÑÊúâÊïàÂØπÈΩê‰∏é‰ø°ÊÅØÊï¥Âêà„ÄÇ

**ÂÖ≥ÈîÆÂàõÊñ∞**ÔºöÊúÄÈáçË¶ÅÁöÑÂàõÊñ∞Âú®‰∫éÂºïÂÖ•‰∫ÜÂ§öÊ®°ÊÄÅSigLIPÊçüÂ§±ÂíåF-RoPEÊ®°ÂùóÔºå‰ΩøÂæóÊ®°ÂûãËÉΩÂ§üÂú®Â§öÁßçÁîüÁâ©Ê®°ÊÄÅ‰πãÈó¥ËøõË°åÊúâÊïàÁöÑÂØπÊØîÂ≠¶‰π†ÂíåÁ©∫Èó¥ÁªìÊûÑ‰øùÁïôÔºåÊòæËëóÊèêÂçá‰∫ÜÊ®°ÂûãÁöÑË°®Áé∞„ÄÇ

**ÂÖ≥ÈîÆËÆæËÆ°**ÔºöÂú®ÊçüÂ§±ÂáΩÊï∞ÊñπÈù¢ÔºåÈááÁî®‰∫ÜÂ§öÊ®°ÊÄÅSigLIPÊçüÂ§±‰ª•ÂÆûÁé∞ÂÖ®ÂØπÊØîÂ≠¶‰π†ÔºõF-RoPEÊ®°ÂùóÂàôÈÄöËøáÊóãËΩ¨‰ΩçÁΩÆÁºñÁ†Å‰øùÁïô‰∫ÜÁªÑÁªáÂàáÁâáÁöÑÁ©∫Èó¥ÁªìÊûÑÔºåÁ°Æ‰øù‰∫Ü‰ø°ÊÅØÁöÑÂÆåÊï¥ÊÄß‰∏éÂáÜÁ°ÆÊÄß„ÄÇ

## üìä ÂÆûÈ™å‰∫ÆÁÇπ

Âú®Patho-BenchÂü∫ÂáÜÊµãËØï‰∏≠ÔºåEXAONE Path 2.5‰∏éÂÖ≠‰∏™È¢ÜÂÖàÁöÑÁóÖÁêÜÂü∫Á°ÄÊ®°ÂûãÁõ∏ÊØîÔºåË°®Áé∞Âá∫Áõ∏ÂΩìÁöÑÊÄßËÉΩÔºå‰∏îÂú®ÂÜÖÈÉ®‰∏¥Â∫äÊï∞ÊçÆÈõÜ‰∏äÂ±ïÁé∞Âá∫ÊúÄÈ´òÁöÑÈÄÇÂ∫îÊÄßÔºåËØÅÊòé‰∫ÜÂÖ∂Âú®Êï∞ÊçÆÂíåÂèÇÊï∞ÊïàÁéá‰∏äÁöÑ‰ºòÂäø„ÄÇ

## üéØ Â∫îÁî®Âú∫ÊôØ

EXAONE Path 2.5Ê®°ÂûãÂú®Á≤æÂáÜËÇøÁò§Â≠¶‰∏≠ÂÖ∑ÊúâÂπøÊ≥õÁöÑÂ∫îÁî®ÊΩúÂäõÔºåËÉΩÂ§ü‰∏∫‰∏™‰ΩìÂåñÊ≤ªÁñóÊèê‰æõÊõ¥‰∏∫ÂÖ®Èù¢ÁöÑÁîüÁâ©Â≠¶‰æùÊçÆ„ÄÇÈÄöËøáÊï¥ÂêàÂ§öÁßçÁîüÁâ©Ê®°ÊÄÅÔºåËØ•Ê®°ÂûãÊúâÂä©‰∫éÊõ¥Â•ΩÂú∞ÁêÜËß£ËÇøÁò§ÁöÑÂèëÁîüÂèëÂ±ïÊú∫Âà∂Ôºå‰ªéËÄåÊé®Âä®Êñ∞ÁñóÊ≥ïÁöÑÁ†îÂèë‰∏é‰∏¥Â∫äÂ∫îÁî®„ÄÇ

## üìÑ ÊëòË¶ÅÔºàÂéüÊñáÔºâ

> Cancer progression arises from interactions across multiple biological layers, especially beyond morphological and across molecular layers that remain invisible to image-only models. To capture this broader biological landscape, we present EXAONE Path 2.5, a pathology foundation model that jointly models histologic, genomic, epigenetic and transcriptomic modalities, producing an integrated patient representation that reflects tumor biology more comprehensively. Our approach incorporates three key components: (1) multimodal SigLIP loss enabling all-pairwise contrastive learning across heterogeneous modalities, (2) a fragment-aware rotary positional encoding (F-RoPE) module that preserves spatial structure and tissue-fragment topology in WSI, and (3) domain-specialized internal foundation models for both WSI and RNA-seq to provide biologically grounded embeddings for robust multimodal alignment. We evaluate EXAONE Path 2.5 against six leading pathology foundation models across two complementary benchmarks: an internal real-world clinical dataset and the Patho-Bench benchmark covering 80 tasks. Our framework demonstrates high data and parameter efficiency, achieving on-par performance with state-of-the-art foundation models on Patho-Bench while exhibiting the highest adaptability in the internal clinical setting. These results highlight the value of biologically informed multimodal design and underscore the potential of integrated genotype-to-phenotype modeling for next-generation precision oncology.

